YD Bio YDESW
NASDAQ YDESW
$0.41 -0.06 (-12.77%)
At close: Sep 8, 2026 · 4:00 PM EDT

YD Bio (YDESW) Other Accumulated Expenses (2024 - 2026)

YD Bio's (YDESW) quarterly Other Accumulated Expenses came in at $358864.0 in Q2 2026, up 462.99% year-over-year from $63743.0 in Q2 2025, and down 54.32% quarter-over-quarter from $785665.0 in Q4 2025.

Analysis

YD Bio (YDESW) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

YD Bio (YDESW) has reported Other Accumulated Expenses for 3 consecutive years, with $358864.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 462.99% year-over-year to $358864.0 in Q2 2026; TTM through Jun 2026 was $358864.0, a 462.99% increase from a year earlier, with the FY2025 full-year figure at $785665.0, up 2009.0% from the prior year.
  • Other Accumulated Expenses was $358864.0 for Q2 2026 at YD Bio, down from $785665.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $785665.0 in Q4 2025 and troughed at $37253.0 in Q4 2024.
  • A 3-year average of $311381.2 and a median of $211303.5 in 2025 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses soared 2009.0% in 2025 and jumped 462.99% in 2026, its largest moves.
  • Over 3 years, Other Accumulated Expenses stood at $37253.0 in 2024, then soared by 2009.0% to $785665.0 in 2025, then sank by 54.32% to $358864.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $358864.0 (Q2 2026), $785665.0 (Q4 2025), and $63743.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.05 Bn 198.06 Bn 7.24 Bn
2 Gilead Sciences 181.76 Bn 178.58 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.46 Bn 124.61 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.66 Bn 74.67 Bn 3.93 Bn
5 Argenx Se 61.56 Bn 56.37 Bn 1.37 Bn
6 Moderna 54.69 Bn 49.56 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn
8 Biogen 31.46 Bn 30.17 Bn 1.96 Bn
9 Roivant Sciences 30.15 Bn 30.15 Bn 1.16 Mn
10 YD Bio 29.02 Mn 26.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 358,864.00
Dec 31, 2025 785,665.00
Jun 30, 2025 63,743.00
Dec 31, 2024 37,253.00